ReviewCureus2024
Helmut Gadner: A Charismatic Leader, Visionary, and Pioneer in Pediatric Oncology.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helmut Gadner, a world-famous pediatric hematologist-oncologist, dedicated his professional life to researching pediatric cancer and advancing care for affected children, adolescents, and their families. Starting his career in the team of Hansjörg Riehm, the father of the ever-most successful BFM (abbreviation of the city names of the founding institutions, Berlin-Frankfurt-Münster) treatment concept of pediatric leukemia, the young Dr. Gadner became a passionate soldier in the fight against pediatric cancer. From 1980 to 2010, he served as a medical director of St. Anna Children's Hospital in Vienna, Austria. Soon after taking this highly responsible position, he realized that improving patient care requires rigorous research from bench to bedside. In 1988, he and others founded St. Anna Children's Cancer Research Institute (St. Anna CCRI), a testament to his visionary spirit, which he headed until his retirement in 2012. His thoughtful leadership and vision were instrumental in establishing St. Anna Children's Hospital and St. Anna CCRI as a worldwide acclaimed center for researching, diagnosing, and treating children and adolescents with cancer within the environment of national and international collaborations and clinical trials. Dr. Gadner's enduring legacy, St. Anna CCRI, recently celebrated its 35
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.